The AMPK allosteric activator MK‐8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle.

MLA

Ravel, Chapuis, Aymeric, et al. “The AMPK Allosteric Activator MK‐8722 Improves the Histology and Spliceopathy in Myotonic Dystrophy Type 1 (DM1) Skeletal Muscle.” FASEB Journal, vol. 38, no. 23, Dec. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1096/fj.202401145RR.

APA

Ravel, C. A., Fahmi, C., Gobin, J., & Jasmin, B. J. (2024). The AMPK allosteric activator MK‐8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle. FASEB Journal, 38(23), 1–14. https://doi.org/10.1096/fj.202401145RR

Chicago

Ravel, Chapuis, Aymeric, Chimène Fahmi, Jonathan Gobin, and Bernard J. Jasmin. 2024. “The AMPK Allosteric Activator MK‐8722 Improves the Histology and Spliceopathy in Myotonic Dystrophy Type 1 (DM1) Skeletal Muscle.” FASEB Journal 38 (23): 1–14. doi:10.1096/fj.202401145RR.